Literature DB >> 17103260

Controversies in surgical oncology: routine anthracycline-based adjuvant chemotherapy for stage III extremity soft tissue sarcoma.

Vivien H C Bramwell1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17103260     DOI： 10.1245/s10434-006-9168-8

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  4 in total

1.  Long-term results of a phase 2 study of neoadjuvant chemotherapy and radiotherapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514.

Authors:  William G Kraybill; Jonathan Harris; Ira J Spiro; David S Ettinger; Thomas F DeLaney; Ronald H Blum; David R Lucas; David C Harmon; G Douglas Letson; Burton Eisenberg
Journal:  Cancer       Date:  2010-10-01       Impact factor: 6.860

Review 2.  Adjuvant chemotherapy in 2011 for patients with soft-tissue sarcoma.

Authors:  Igor Matushansky; Robert N Taub
Journal:  Nat Rev Clin Oncol       Date:  2011-03-22       Impact factor: 66.675

3.  Chemotherapy influences the pseudocapsule composition in soft tissue sarcomas.

Authors:  Patrick W O'Donnell; J Carlos Manivel; Edward Y Cheng; Denis R Clohisy
Journal:  Clin Orthop Relat Res       Date:  2014-03       Impact factor: 4.176

4.  Neoadjuvant chemoradiation therapy for soft tissue sarcomas of the extremities.

Authors:  Samuel Aguiar Junior; Fábio de Oliveira Ferreira; Benedito Mauro Rossi; Erika Maria Monteiro Santos; João Victor Salvajoli; Ademar Lopes
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.